These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 1794931)

  • 1. Insulin resistance in visceral obesity.
    Kissebah AH
    Int J Obes; 1991 Sep; 15 Suppl 2():109-15. PubMed ID: 1794931
    [No Abstract]   [Full Text] [Related]  

  • 2. [Visceral adipose tissue and metabolic syndrome].
    Blüher M; Paschke R
    Dtsch Med Wochenschr; 2003 Oct; 128(44):2319-23. PubMed ID: 14593576
    [No Abstract]   [Full Text] [Related]  

  • 3. Contribution of visceral obesity to the insulin resistance syndrome.
    Lemieux S
    Can J Appl Physiol; 2001 Jun; 26(3):273-90. PubMed ID: 11441231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Insulin resistance syndrome, visceral fat syndrome].
    Nakamura T; Matsuzawa Y
    Nihon Rinsho; 1997 Nov; 55 Suppl():792-8. PubMed ID: 9434566
    [No Abstract]   [Full Text] [Related]  

  • 5. [Metabolic difference between visceral fat and subcutaneous abdominal fat].
    Björntorp P
    Diabetes Metab; 2000 Jun; 26 Suppl 3():10-2. PubMed ID: 10945144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Glucose intolerance in visceral fat syndrome].
    Matsuzawa Y
    Nihon Rinsho; 2002 Jul; 60 Suppl 7():746-51. PubMed ID: 12238130
    [No Abstract]   [Full Text] [Related]  

  • 7. [Significance of visceral fat syndrome in pathogenesis of impaired glucose tolerance].
    Nakamura T
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():246-9. PubMed ID: 15779380
    [No Abstract]   [Full Text] [Related]  

  • 8. Resistin and adiponectin expression in visceral fat of obese rats: effect of weight loss.
    Milan G; Granzotto M; Scarda A; Calcagno A; Pagano C; Federspil G; Vettor R
    Obes Res; 2002 Nov; 10(11):1095-103. PubMed ID: 12429872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A transgenic model of visceral obesity and the metabolic syndrome.
    Masuzaki H; Paterson J; Shinyama H; Morton NM; Mullins JJ; Seckl JR; Flier JS
    Science; 2001 Dec; 294(5549):2166-70. PubMed ID: 11739957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thermodynamics, liposuction, and metabolism.
    Kelley DE
    N Engl J Med; 2004 Jun; 350(25):2542-4. PubMed ID: 15201408
    [No Abstract]   [Full Text] [Related]  

  • 11. Growth hormone--ready for prime time?
    Marcus R; Reaven GM
    J Clin Endocrinol Metab; 1997 Mar; 82(3):725-6. PubMed ID: 9062472
    [No Abstract]   [Full Text] [Related]  

  • 12. Depot-specific hormonal characteristics of subcutaneous and visceral adipose tissue and their relation to the metabolic syndrome.
    Wajchenberg BL; Giannella-Neto D; da Silva ME; Santos RF
    Horm Metab Res; 2002; 34(11-12):616-21. PubMed ID: 12660870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Resistine--a new hormone secreted by adipose tissue (adipose tissue in insulin resistance)].
    Kochan Z; Karbowska J
    Przegl Lek; 2003; 60(1):40-2. PubMed ID: 12884646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoprotein metabolism in visceral obesity.
    Després JP
    Int J Obes; 1991 Sep; 15 Suppl 2():45-52. PubMed ID: 1794938
    [No Abstract]   [Full Text] [Related]  

  • 15. Relationship between visceral adiposity and intramyocellular lipid content in two rat models of insulin resistance.
    Korach-André M; Gao J; Gounarides JS; Deacon R; Islam A; Laurent D
    Am J Physiol Endocrinol Metab; 2005 Jan; 288(1):E106-16. PubMed ID: 15328072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The insulin resistance-dyslipidemic syndrome: contribution of visceral obesity and therapeutic implications.
    Després JP; Lemieux S; Lamarche B; Prud'homme D; Moorjani S; Brun LD; Gagné C; Lupien PJ
    Int J Obes Relat Metab Disord; 1995 May; 19 Suppl 1():S76-86. PubMed ID: 7550542
    [No Abstract]   [Full Text] [Related]  

  • 17. Visceral fat obesity: anthropological and pathophysiological aspects.
    Tarui S; Tokunaga K; Fujioka S; Matsuzawa Y
    Int J Obes; 1991 Sep; 15 Suppl 2():1-8. PubMed ID: 1794929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adipose tissue dysfunction in obesity.
    Blüher M
    Exp Clin Endocrinol Diabetes; 2009 Jun; 117(6):241-50. PubMed ID: 19358089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of visceral fat obesity.
    Fujioka S; Matsuzawa Y; Tokunaga K; Keno Y; Kobatake T; Tarui S
    Int J Obes; 1991 Sep; 15 Suppl 2():59-65. PubMed ID: 1794940
    [No Abstract]   [Full Text] [Related]  

  • 20. Adipose tissue renin-angiotensin-aldosterone system (RAAS) and progression of insulin resistance.
    Marcus Y; Shefer G; Stern N
    Mol Cell Endocrinol; 2013 Sep; 378(1-2):1-14. PubMed ID: 22750719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.